Skip to main content

The Antimicrobial Use and Resistance in Australia (AURA) Surveillance System collects, reviews and analyses data on antimicrobial use and antimicrobial resistance in human health.

2022
Standard

This complete version of the Opioid Analgesic Stewardship in Acute Pain Clinical Care Standard describes what each quality statement means for patients and their families, clinicians, and health service organisations, and provides indicators for local monitoring. It includes information about using clinical care standards, and the background and evidence sources for this standard.

The Commission, in consultation with the National Pathology Accreditation Advisory Council (NPAAC), advises of an amendment to the confirmatory testing for HIV and HCV of the Requirements for laboratory testing for human immunodeficiency virus (HIV) and hepatitis C virus (HCV).

The Commission, in consultation with the National Pathology Accreditation Advisory Council (NPAAC), advises of an amendment to the language in Action 1.01 of the Requirements for Medical Testing for Human Genetic Variation.

The Commission, in consultation with the National Pathology Accreditation Advisory Council (NPAAC), advises of an amendment to the Requirements for the Development and Use of In-House In Vitro Diagnostic (IVD) Medical Devices.

The Commission has collaborated with the Australian Digital Health Agency to develop advice on how to improve user experience in My Health Record (MHR) viewing platforms in acute care settings.

2026
Guide, user guide or guidelines

The Usability Guidance for Optimising My Health Record Viewing Platforms in Acute Care (the Guide) provides advice to software vendors and viewing platform owners on how to improve the user experience of viewing platforms that interface with My Health Record – Australia’s national electronic health record platform.

Back to top